Search Results

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are...

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are...

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are...

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are...

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are...

This study will examine receipt of depression care and perceived helpfulness of depression care among adults with major depressive episodes (MDE) and with and without comorbid SUD.

Depression Care among Depressed Adults with and without Comorbid Substance Use Disorders in the United States 

This spotlight uses the 2015 National Survey on Drug Use and Health to examine the relationship between serious mental illness and past year opioid use among adults aged 18 or older.

This report uses the combined 2007 to 2012 National Surveys on Drug Use and Health (NSDUHs), the 2012 Treatment Episode Data Set (TEDS), and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to examine opioid use and treatment among women of childbearing age (aged 15 to 44).

This study examines the impact of prescription drug monitoring programs on nonmedical use of prescription drugs and heroin. It was funded using FY16 ASC dollars.

Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health.

This report details the changes to trends for specific questionnaire items resulting from the 2015 NSDUH questionnaire redesign.

This CBHSQ short report uses data from the 2011 Treatment Episode Data Set – Discharges (TEDS-D) and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to provide a portrait of treatment discharges among those referred to treatment by the criminal justice system, hereafter referred to as criminal justice...

This spotlight uses 2013 The Treatment Episode Data Set (TEDS) to examine substance abuse treatment admissions among veterans and nonveterans. Substance abuse treatment admissions were analyzed for alcohol, heroin, cocaine, marijuana, methamphetamine, and other opioids and synthetics.

Describes emergency department (ED) visits involving the nonmedical use of narcotic pain relievers (opioids) using data from the Drug Abuse Warning Network (DAWN). The drugs most commonly combined with narcotic pain relievers in ED visits; trends for narcotic pain relievers (2005-2011); demographic characteristics of narcotic pain reliever-related visits in 2011...

This report looks at costs for substance use disorder treatment reported in the 2010 National Ambulatory Medical Care Survey. These data include costs for prescriptions for medications and behavioral treatment used to treat alcohol use disorders and opioid use disorders made in office visits to general and family practice physicians...

This report presents data from the 2002 through 2014 National Surveys on Drug Use and Health (NSDUHs) for trends in people’s perceptions of great risk of harm associated with the use of cigarettes, alcohol, and specific illicit drugs and the perceived availability of substances. The data are presented for the...